1. Home
  2. Events
  3. 3rd Kyoto University LifeScience Showcase@San Diego 2022

Registration

3rd Kyoto University LifeScience Showcase@San Diego 2022

The 3rd Kyoto University LifeScience Showcase @San Diego 2022 is designed to be of particular interest to the Angel, VC investor communities, and potential strategic alliance partners. The showcase will feature virtual presentations from 16 selected Life Science companies from Japan and the US seeking funding and strategic alliances. Please review the event information below and register at your earliest opportunity.

Form of Event
Showcase
Date and Time
March 1, 2022 2pm PST
March 2, 2022 7am JST
Target participants
-Investors, Venture capitalists, Angels
-Pharmaceutical companies, Medical device companies
-Entrepreneurs from UCSD, Kyoto university, and other academic institutions
Venue
Online (Zoom Webinar)
Participation Fee
Free of charge
Details and Registration
Registration

Program

* The program is subject to change.
* At the end of each presentation, we will ask everyone to vote for their evaluation and the results will be used to determine the Audience Award.

2:00pm(PST)
Opening Remarks
2:05pm(PST)
Session1 “Immunology and infectious diseases”
*sponsored by Kyoto University
KinoPharma Inc.
Novel antiviral agent in clinical stage for HPV infection
CarbGeM Inc.
Combating antimicrobial resistance with AI
Rebirthel Co., Ltd.
Development of off-the-shelf T cell therapy for cancer and viral infection using the iPS cell technology
SUDx-Biotec Corporation
Chimeric Antigen Receptor expressed Natural Killer Cells for the treatment of Adult T-cell Leukemia (CAR-NK for ATL)
2:50pm(PST)
Session 2 "Medical devices"
*sponsored by LINK-J
Lilac pharma Inc.
Our microfluidic technology unlocks a future of individualized mRNA vaccine therapy
R-NanoBio Co. Ltd.
Multiple analysis system at a clinic
Triple W
DFree - Wearable device for urinary incontinence
AquaTeX Medical
Aqua Embolic System: Novel Liquid Embolic System for Endovascular Surgery
3:35pm(PST)
Session 3 "Small molecule therapeutics"
*sponsored by FBRI
Takaha Pharmaceutical Co. Ltd.
Development of ATP enhancer [a combination drug of febuxostat and inosine] effective for mitochondrial disease, Parkinson’s disease, and dementia
BTB Drug Development Research Center
Non-addictive, non-opioid, post-NSAID painkiller
NATiAS Inc.
Contributing to Global Healthcare through Innovation of Oligonucleotide Synthesis Technology
Autoimmunity BioSolutions
Correcting Immunity with Targeted Therapies (MS, immuno-oncology)
4:20pm(PST)
Session 4 "Regenerative medicine"
*sponsored by JETRO
PuREC Co., Ltd.
Bone/Cartilage Regeneration by Uniquely Purified MSC, “REC”
CUORiPS Inc.
Introduction of CUORiPS Inc.
HiLung Inc.
Human Respiratory Cell Regeneration
Oligogen, Inc.
Novel stem cell treatment for central nervous system disorders
5:05pm(PST)
Award ceremony
5:20pm(PST)
Closing remarks
5:25pm(PST)
Adjourn